Is the Georgian Institute of Reproductive Medicine Good? | Real Patient Experiences & Medical Evaluation

Analyzing the actual medical level of the Georgian Institute of Reproductive Medicine (GGRS) from dimensions such as real patient experiences, doctor team configuration, laboratory standards, success rate data, and cost composition. Suitable for those with normal ovarian function seeking third-generation IVF, but caution is advised for older individuals and those with very low follicle reserve.

Is the Georgian Institute of Reproductive Medicine Good? | Real Patient Experiences & Medical Evaluation
Surrogacy Guide 2026-07-01

People who first encounter this institution generally ask three questions

A 37-year-old patient, with AMH 1.8 ng/mL, had previously failed one IVF attempt domestically. She brought her complete set of examination reports and asked through online consultation: "Is the Georgian Institute of Reproductive Medicine (GGRS) reliable? Is it worth flying there specifically?" This is a typical profile of an older patient with acceptable ovarian reserve but a history of failure. Her core need is not "is it expensive," but "can it succeed, what are the risks, and is the process transparent."

Direct Answer: Who GGRS is Suitable For and Unsuitable For

Suitable for:

  • Basically normal ovarian function (AMH ≥ 1.0 ng/mL, Antral Follicle Count AFC > 7)
  • Genetic disease carriers or patients with recurrent miscarriage requiring Preimplantation Genetic Testing (PGT-A/PGT-M)
  • Those with a clear need for gender selection where local law permits
  • Those willing to accept Eastern European medical system pricing (40%-60% cheaper than the US)
  • Those with relatively flexible time, able to stay for at least one ovarian stimulation cycle (approximately 15-18 days)

Unsuitable for:

  • Severely diminished ovarian reserve with AMH < 0.5 ng/mL (egg donation protocol may be more efficient)
  • Complicated with severe endometrial pathology (e.g., intrauterine adhesions, endometrial tuberculosis) that has not been treated
  • Clear thrombotic tendency or uncontrolled chronic diseases (need stabilization domestically first)
  • Extremely high demand for communication efficiency (English/Russian primarily, limited Chinese coordinators)

Why the Question "Is it Good" Arises – Analysis of Core Controversies

Founded in 2014 and located in Tbilisi, GGRS is one of the first private reproductive centers in Georgia to obtain Ministry of Health permission for third-generation IVF. Controversies mainly stem from three aspects:

  • Confusing Information Sources: The Chinese internet contains both promotional articles from agencies claiming "high success rates and good service" and personal complaints about "assembly-line operations and communication difficulties," lacking neutral third-party evaluations.
  • Non-transparent Success Rate Data: Official promotion states "frozen embryo transfer clinical pregnancy rate above 65%," but it does not differentiate by age, oocyte source (own egg/donor egg), or whether PGT was performed. Any data not stratified by age or counted by transfer number has discounted reference value.
  • Legal and Ethical Gray Areas: Georgia allows commercial surrogacy and egg donation, but relevant legal details (e.g., surrogate age limits, embryo handling regulations) still have room for interpretation in practice. Some patients have disputes due to unclear contract terms.

Doctor's Perspective: Medical Team Configuration and Laboratory Standards

GGRS's core doctor team is represented by reproductive medicine specialist Dr. Tamara Kiknadze, who trained at the University Hospital Freiburg in Germany. However, it needs to be clarified:

  • Initial consultations are usually translated by a coordinator, with the doctor directly reviewing reports for about 15-20 minutes. For complex cases (e.g., repeated implantation failure, immune infertility), the doctor may request additional tests (e.g., ERA endometrial window testing, chronic endometritis evaluation), but can these be performed locally? The answer is: some tests are sent to Turkey or Germany, resulting in longer waiting periods.
  • The laboratory is key: GGRS has an independent embryology lab equipped with time-lapse incubators (EmbryoScope), laser hatching system, and PGT conditions (NGS sequencing). The lab quality is certified by ISO 15189, but patients can hardly verify the validity and periodic review status of this certification. It is recommended to request the most recent external quality assessment report from CAP (College of American Pathologists) or UK NEQAS (United Kingdom National External Quality Assessment Service).

Differences in Actual Patient Experience by Age Group

Age Group Own Egg Success Rate (Rough Estimate) Common Difficulties GGRS Feedback
≤35 yearsModerately high (40%-50%/transfer cycle)Risk of Ovarian Hyperstimulation SyndromeStimulation protocol is standard, high proportion of fresh embryo transfers
35-40 yearsModerate (30%-40%/transfer cycle)Uneven follicles, increased embryo aneuploidy ratePGT-A recommended, but transfer rate after whole embryo freezing for chromosomal abnormalities may decrease
≥40 yearsLow (15%-25%/transfer cycle)Low follicle count, poor embryo qualityDoctor will directly suggest considering egg donation, higher rejection rate
≥43 yearsVery low (<10%)Almost only egg donation optionPatients insisting on own eggs may be discouraged

The above data is synthesized from multiple patient community feedback and public literature, not official GGRS data. Success rates are highly influenced by individual factors and cannot be extrapolated to individuals.

Easily Overlooked Details: Validity of Examination Reports and Cross-border Process

Many patients assume they can directly use tests done domestically. In reality, GGRS has strict time requirements for the following:

  • Infectious disease screening (HIV, Hepatitis B, Syphilis, etc.): Valid for 3 months, must be redone if expired.
  • Chromosomal karyotype analysis: Permanently valid, but must have a Chinese or English version report; local translations are not accepted.
  • AMH: Valid for 6 months, but usually accepted if levels haven't fluctuated significantly.
  • Hysteroscopy/Endometrial biopsy: For repeated implantation failure patients, results within 1 year are required; otherwise, it must be done locally in Tbilisi.

Most common pitfall: Some patients, guided by agencies, fly directly only to be told upon arrival that important tests have expired, forcing them to pay for urgent local testing, wasting both time and money. It is strongly recommended to send all reports to the medical department for pre-review at least 4 weeks before departure to confirm validity before booking tickets.

Actual Process: Timeline from Consultation to Transfer

  1. Initial Consultation (Online): Submit basic tests from the last 3 months (sex hormone panel, AMH, ultrasound, semen analysis).
  2. Protocol Development (Online): Doctor provides an estimated stimulation protocol (long protocol/antagonist protocol) and cost estimate based on reports.
  3. Travel Planning to Georgia: Stimulation usually starts on day 2-3 of menstruation, requiring a stay of 15-18 days (egg retrieval + fresh embryo transfer); if freezing all embryos, departure is possible in about a week.
  4. Stimulation and Monitoring: Transvaginal ultrasound + blood draw every 1-2 days. Local nurses have limited English proficiency; it's advisable to bring a translation app.
  5. Egg/Sperm Retrieval: Egg retrieval under anesthesia; partner can provide sperm the same day; if the male cannot be present, sperm can be frozen in advance (freezing conditions must be confirmed beforehand).
  6. Embryo Culture/PGT: Blastocyst biopsy on day 5-6, sent for NGS (results in about 2-3 weeks).
  7. Transfer Preparation: Endometrial preparation (natural or artificial cycle), confirmation of transfer date.
  8. Pregnancy Test: Blood test for β-hCG 12-14 days after transfer.

Note: A PGT cycle requires at least two trips to Georgia (one for retrieval, one for transfer), with a total timeline potentially spanning 4-6 months. If choosing egg donation or surrogacy, the timeline is more complex; it is recommended to sign a detailed schedule with the medical coordinator.

Case Scenario Analysis: Someone Who Qualified but Ultimately Gave Up

A 39-year-old patient, AMH 1.2, husband with mild oligoasthenospermia. After reading online guides, she contacted GGRS and found the following issues:

  • The doctor suggested PGT-A directly, but the couple's karyotypes were normal. She believed third-generation IVF carries a risk of embryo loss, and the local PGT fee is per embryo (about 300 euros/embryo), which might not be cost-effective if few eggs are retrieved.
  • She also compared another Georgian hospital (XX Reproductive Center), which offered a "success package" (three transfers, partial refund if unsuccessful). GGRS does not offer such packages, only charging per procedure.
  • She ultimately chose based on cost-effectiveness. However, caution is needed: success packages often come with higher cycle initiation conditions (e.g., requiring AMH ≥ 1.0, age ≤ 38) and strict withdrawal clauses. There is no absolute "good" or "bad," only matching one's medical needs.

Cost Factors: What are the Hidden Expenses

GGRS official standard price list (in USD):

  • Initial consultation + basic test package: $500-$800
  • Ovarian stimulation medications (including injections, monitoring): $2000-$3500 (depending on dosage)
  • Egg retrieval + IVF + embryo culture: $3500-$5000
  • PGT-A (per embryo): $300-$400
  • Frozen embryo transfer: $2500-$3000
  • Egg donation package (including compensation): $8000-$12000

Easily overlooked hidden costs:

  • Translation fee: Full-time Chinese coordinator service fee approximately $1000-$2000 (depending on service duration)
  • Visa, flights, accommodation: At least $2000-$4000 (estimated for a 2-week stay)
  • Additional medication: If response is poor, stimulation drugs may double
  • Additional tests (e.g., ERA, immune screening): $1500-$3000
  • Frozen embryo storage renewal: $200-$400/year

A simple conclusion: Total cost for a single own-egg stimulation and transfer cycle is approximately $12,000-$18,000 (including travel), while egg donation costs $20,000-$30,000. This offers a clear price advantage compared to the US ($30,000-$50,000) but is higher than Thailand ($10,000-$15,000).

Practitioner's Observation: The Most Overestimated "One-on-One with Doctor"

In reality, GGRS doctors see about 15-20 couples per day, with limited time per consultation. Egg retrieval surgery is performed by the doctor team, but ultrasound monitoring may be done by nurses. Patients often report: "During stimulation, besides blood draws, I rarely saw the doctor; nurses adjusted the medication according to the protocol." This does not necessarily mean poor medical quality – standardized processes can reduce individual errors. However, if you require frequent communication and want the doctor deeply involved in every decision, you might need to choose a smaller clinic offering "direct doctor access."

Additionally, the knowledge level of Chinese coordinators varies. Some can accurately translate medical terminology, while others can only handle everyday conversation. It is strongly recommended to learn basic reproductive English vocabulary (e.g., "follicle," "endometrium," "progesterone") before departure to avoid critical information misunderstandings.

How to Determine if This Institution is Right for You

Don't just look at the "success rate" or "patient testimonials" recommended by agencies. It is recommended to evaluate using the following steps:

  • Step 1: Request complete medical qualification documents: including Ministry of Health license, laboratory certification, doctor's practice certificate (English version can be requested).
  • Step 2: Request real success rate data from the last 12 months, stratified by age and number of transfer cycles (WHO recommended standardized report format). If they refuse or only provide an "average rate," disregard them.
  • Step 3: Request one free remote video consultation (15 minutes is enough) to observe whether the doctor is willing to answer your specific questions or just repeats standard phrases.
  • Step 4: Join patient communities (Facebook groups, Telegram groups) to read real feedback from the last six months, paying special attention to cases of "treatment termination" and "refund disputes."
  • Step 5: If considering egg donation or surrogacy, request the complete health screening checklist for the donor/surrogate (including genetic carrier screening, psychological evaluation) and clarify the legal aspects (birth certificate, parental rights).

Doctor's Advice: Don't Just Focus on "Is it Good," Ask "Does it Match"

Finally, back to the 37-year-old patient at the beginning. After weighing her options, she did not choose GGRS but went to another smaller hospital where the doctor followed the entire process. Her reasoning: "My AMH is not high, I need the doctor to be more precise with medication; the assembly-line model is not for me." This decision is not about right or wrong, but about matching.

If you are currently considering GGRS, remember: The core value of any assisted reproduction institution lies in the quality of its embryology lab and the execution capability of its medical team, not its marketing packaging. First, complete a full fertility assessment, then compare the pros and cons in this article and list your own priority checklist. If conditions permit, it is advisable to have an online consultation first to gauge the smoothness of communication.

Finally, assisted reproduction involves uncertainty. Regardless of where you choose, you should be mentally and financially prepared for the "worst-case scenario." Do not dismiss a hospital because of one failure, nor blindly trust it because of one "success story." Managing expectations is more important than any institution itself.

Comments (0)

Leave a Comment